In this issue
Can early treatment slow disease progression in patients with relapsing multiple sclerosis?
Regina Berkovich and Robert Shin share their insights for this article on the evolving role of a selective S1P receptor modulator in early relapsing multiple sclerosis.
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.
Latest articles
All articles

We’ve noticed you’re accessing
from North/South America.
from North/South America.